access to glp 1 medications The Case for Expanding Weight-Loss - March 12, 2026 The GLP-1 Drugs Revolution: How

New Orleans, LA

Further, the role of GLP-1 RAs in the treatment of AUD is a promising area of research

Abstract Objective: Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) lower plasma glucose through effects on insulin and glucagon secretion and by decelerating gastric emptying

If it continues, GERD can cause scarring and narrowing of the esophagus and increase a persons risk of esophageal cancer.Results show that people taking GLP-1 drugs were 27% more likely to develop GERD and 55% more likely to have GERD complications, when compared to people taking SGLT-2 inhibitors.More than 90% of GERD complications involved Barrett esophagus, in which acid damage changes the tissue lining of the esophagus and increases cancer risk, researchers noted.We also found that the risk for GERD was higher with long-acting GLP-1 (drug) use, researchers wrote.However, they noted that these findings need to be verified by studies involving other groups, including those taking GLP-1 drugs for obesity.There is limited evidence on the risk for GERD among patients with obesity who do not have type 2 diabetes, researchers wrote